BillionToOne, Inc. (BLLN)

BillionToOne will go public soon. The estimated IPO date is November 6, 2025.
IPO Price Range
$49.00 - $55.00
Shares Offered
3,846,000
Deal Size
$199.99M
Chart not available yet
Data will show when the stock starts trading on Nov 6, 2025.
Market Cap2.29B
Revenue (ttm)209.03M
Net Income (ttm)-30.62M
Shares Out 44.02M
EPS (ttm)-0.70
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About BLLN

BillionToOne is transforming healthcare by redefining molecular diagnostics. Our revolutionary single molecule NGS (smNGS) platform achieves what was once thought impossible – detecting and precisely quantifying genetic targets with single-molecule sensitivity. Our superior technology platform has enabled us to build category-defining prenatal and oncology products. Our products reveal actionable insights from a simple blood draw that are fundamentally changing how diseases are diagnosed and treated, leading to a paradigm shift in personalized ... [Read more]

Sector Healthcare
IPO Date Nov 6, 2025
Employees 620
Stock Exchange NASDAQ
Ticker Symbol BLLN
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

BillionToOne targets over $2 billion valuation in US IPO

Molecular diagnostics firm BillionToOne said on Friday it was aiming at a valuation of up to $2.42 billion in its U.S. initial public offering.

11 days ago - Reuters

BillionToOne Launches IPO In Slowing IPO Market

BillionToOne, Inc. is rapidly growing in the prenatal and oncology diagnostics sectors, nearing operating breakeven, and has filed for a $100 million IPO. BLLN's revenue is driven mainly by its UNITY ...

15 days ago - Seeking Alpha

U.S. IPO Weekly Recap: 6 IPOs Debut, Pipeline Grows, Despite Government Shutdown

Six IPOs debuted this week, while two SPACs listed. Thirteen IPOs and five SPACs also submitted initial filings. No traditional IPOs are currently scheduled for the week ahead as the government shutdo...

17 days ago - Seeking Alpha

Molecular diagnostics firm BillionToOne files for US IPO

BillionToOne filed for an initial public offering in the United States on Tuesday.

21 days ago - Reuters

BillionToOne IPO Registration Document (S-1)

BillionToOne has filed to go public with an IPO on the NASDAQ.

21 days ago - SEC